Pelvic Exenteration with En Bloc Iliac Vessel Resection for Lateral Pelvic Wall Involvement

被引:127
作者
Austin, Kirk K. S.
Solomon, Michael J.
机构
[1] Univ Sydney, Dept Colorectal Surg, Sydney, NSW 2006, Australia
[2] Univ Sydney, Royal Prince Alfred Hosp, Surg Outcome Res Ctr, Sydney, NSW 2006, Australia
[3] Univ Sydney, Discipline Surg, Sydney, NSW 2006, Australia
关键词
Pelvic exenteration; Recurrence; Lateral pelvic wall; RECURRENT RECTAL-CANCER; TOTAL MESORECTAL EXCISION; SURGERY; RADIOTHERAPY; CARCINOMA; PATTERNS;
D O I
10.1007/DCR.0b013e3181a73f48
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
PURPOSE: Lateral pelvic recurrence is considered a poor prognostic variable and a relative contraindication to surgery because of the difficulty in achieving clear margins. The aim of this study was to outline our surgical approach to lateral pelvic sidewall involvement and assess the oncologic and long-term outcomes. METHODS: A retrospective review of a prospective database was performed. Patient demographics, cancer and operative details, intent, margins, lymph node status, rerecurrence at resection site, follow-up, living and death details were assessed. RESULTS: En bloc lateral pelvic wall dissection and vascular resection with pelvic exenteration was performed in 36 patients of 107 exenterations. All patients underwent surgery with curative intent. Negative margins were achieved in 19 patients (53%). Ten patients (28%) developed recurrence at the site of resection compared with 26 patients (72%) who remained disease free at the site of surgery. Sixteen patients (46%) are disease-free with the average disease-free interval of 30 months. Twenty-five patients (69%) are alive with a mean follow-up of 19 months. No mortalities occurred in this cohort of patients. CONCLUSION: Despite the complexity of this technique, it is safe and feasible. Careful preoperative radiologic assessment and a multidisciplinary approach are paramount to achieving clear margins.
引用
收藏
页码:1223 / 1233
页数:11
相关论文
共 24 条
  • [1] Bartelink H, 2001, Ned Tijdschr Geneeskd, V145, P2259
  • [2] CASS AW, 1976, CANCER-AM CANCER SOC, V37, P2861, DOI 10.1002/1097-0142(197606)37:6<2861::AID-CNCR2820370643>3.0.CO
  • [3] 2-3
  • [4] AGGRESSIVE SURGICAL-MANAGEMENT OF LOCALLY ADVANCED PRIMARY AND RECURRENT RECTAL-CANCER - CURRENT STATUS AND FUTURE-DIRECTIONS
    COHEN, AM
    MINSKY, BD
    [J]. DISEASES OF THE COLON & RECTUM, 1990, 33 (05) : 432 - 438
  • [5] RADIOTHERAPY OF PRESACRAL RECURRENCE FOLLOWING RADICAL SURGERY FOR RECTAL-CARCINOMA
    DOBROWSKY, W
    SCHMID, AP
    [J]. DISEASES OF THE COLON & RECTUM, 1985, 28 (12) : 917 - 919
  • [6] Gray R, 2001, LANCET, V358, P1291
  • [7] Curative potential of multimodality therapy for locally recurrent rectal cancer
    Hahnloser, D
    Nelson, H
    Gunderson, LL
    Hassan, I
    Haddock, MG
    O'Connell, MJ
    Cha, S
    Sargent, DJ
    Horgan, A
    [J]. ANNALS OF SURGERY, 2003, 237 (04) : 502 - 508
  • [8] THE MESORECTUM IN RECTAL-CANCER SURGERY - THE CLUE TO PELVIC RECURRENCE
    HEALD, RJ
    HUSBAND, EM
    RYALL, RDH
    [J]. BRITISH JOURNAL OF SURGERY, 1982, 69 (10) : 613 - 616
  • [9] TOTAL MESORECTAL EXCISION IS OPTIMAL SURGERY FOR RECTAL-CANCER - A SCANDINAVIAN CONSENSUS
    HEALD, RJ
    [J]. BRITISH JOURNAL OF SURGERY, 1995, 82 (10) : 1297 - 1299
  • [10] Extended radical resection: The choice for locally recurrent rectal cancer
    Heriot, Alexander G.
    Byrne, Christopher M.
    Lee, Peter
    Dobbs, Bruce
    Tilney, Henry
    Solomon, Michael J.
    Mackay, John
    Frizelle, Frank
    [J]. DISEASES OF THE COLON & RECTUM, 2008, 51 (03) : 284 - 291